Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	LRRC37AB_C	LRRC37A LRRC37A3 LRRC37A2	1.20e-07	4	59	3	PF14914
Domain	LRRC37_N	LRRC37A LRRC37A3 LRRC37A2	1.20e-07	4	59	3	IPR032754
Domain	LRRC37AB_C	LRRC37A LRRC37A3 LRRC37A2	1.20e-07	4	59	3	IPR029423
Domain	LRRC37	LRRC37A LRRC37A3 LRRC37A2	1.20e-07	4	59	3	PF15779
Domain	LRRC37A/B-like	LRRC37A LRRC37A3 LRRC37A2	1.20e-07	4	59	3	IPR015753
Domain	ICAM	ICAM5 ICAM3	5.86e-05	4	59	2	IPR003988
Domain	ICAM_N	ICAM5 ICAM3	9.75e-05	5	59	2	IPR013768
Domain	ICAM_N	ICAM5 ICAM3	9.75e-05	5	59	2	PF03921
Domain	ICAM_VCAM_N	ICAM5 ICAM3	1.46e-04	6	59	2	IPR003987
Domain	LDLR_class-A_CS	TMPRSS15 SSPOP ST14	2.72e-04	40	59	3	IPR023415
Domain	Ldl_recept_a	TMPRSS15 SSPOP ST14	3.87e-04	45	59	3	PF00057
Domain	-	TMPRSS15 SSPOP ST14	4.13e-04	46	59	3	4.10.400.10
Domain	LDLRA_1	TMPRSS15 SSPOP ST14	4.68e-04	48	59	3	PS01209
Domain	LDLRA_2	TMPRSS15 SSPOP ST14	4.98e-04	49	59	3	PS50068
Domain	LDrepeatLR_classA_rpt	TMPRSS15 SSPOP ST14	4.98e-04	49	59	3	IPR002172
Domain	LDLa	TMPRSS15 SSPOP ST14	4.98e-04	49	59	3	SM00192
Domain	SEA	TMPRSS15 ST14	2.18e-03	22	59	2	PF01390
Domain	G_patch	SUGP2 RBM6	2.38e-03	23	59	2	SM00443
Domain	G_patch_dom	SUGP2 RBM6	2.38e-03	23	59	2	IPR000467
Domain	G_PATCH	SUGP2 RBM6	2.38e-03	23	59	2	PS50174
Domain	SEA	TMPRSS15 ST14	2.38e-03	23	59	2	PS50024
Domain	G-patch	SUGP2 RBM6	2.38e-03	23	59	2	PF01585
Domain	SEA_dom	TMPRSS15 ST14	2.38e-03	23	59	2	IPR000082
Domain	TGFb_propeptide	MSTN GDF11	3.52e-03	28	59	2	PF00688
Domain	TGF-b_N	MSTN GDF11	3.52e-03	28	59	2	IPR001111
Domain	LRR	NLRP12 LRRC37A LRRC37A3 LRRC37A2	3.73e-03	201	59	4	PS51450
Domain	ZnF_U1	ZFHX4 ZNF407	3.77e-03	29	59	2	SM00451
Domain	Znf_U1	ZFHX4 ZNF407	3.77e-03	29	59	2	IPR003604
Domain	TGF-beta-rel	MSTN GDF11	4.58e-03	32	59	2	IPR015615
Domain	TGFb_CS	MSTN GDF11	4.58e-03	32	59	2	IPR017948
Domain	ConA-like_dom	TMPRSS15 CELSR1 TRIM58 RNF39	5.06e-03	219	59	4	IPR013320
Domain	zf-C3HC4	RAPSN TRIM58 VPS8 RNF39	5.39e-03	223	59	4	PF00097
Domain	TGFB	MSTN GDF11	6.09e-03	37	59	2	SM00204
Domain	TGF-b_C	MSTN GDF11	6.09e-03	37	59	2	IPR001839
Domain	TGF_BETA_2	MSTN GDF11	6.09e-03	37	59	2	PS51362
Domain	TGF_beta	MSTN GDF11	6.09e-03	37	59	2	PF00019
Domain	TGF_BETA_1	MSTN GDF11	6.09e-03	37	59	2	PS00250
Domain	PRY	TRIM58 RNF39	7.79e-03	42	59	2	PF13765
Pubmed	Primate segmental duplication creates novel promoters for the LRRC37 gene family within the 17q21.31 inversion polymorphism region.	LRRC37A LRRC37A3 LRRC37A2	1.85e-08	4	59	3	22419166
Pubmed	Evolutionary dynamism of the primate LRRC37 gene family.	LRRC37A LRRC37A3 LRRC37A2	5.52e-07	10	59	3	23064749
Pubmed	GDF11 promotes osteogenesis as opposed to MSTN, and follistatin, a MSTN/GDF11 inhibitor, increases muscle mass but weakens bone.	MSTN GDF11	2.83e-06	2	59	2	32071240
Pubmed	The Growth Differentiation Factor 11 (GDF11) and Myostatin (MSTN) in tissue specific aging.	MSTN GDF11	2.83e-06	2	59	2	28472635
Pubmed	Relationship between serum level of growth differentiation factors 8, 11 and bone mineral density in girls with anorexia nervosa.	MSTN GDF11	2.83e-06	2	59	2	30281844
Pubmed	Circulating Growth Differentiation Factor 11/8 Levels Decline With Age.	MSTN GDF11	2.83e-06	2	59	2	26489925
Pubmed	Functional substitutions of amino acids that differ between GDF11 and GDF8 impact skeletal development and skeletal muscle.	MSTN GDF11	2.83e-06	2	59	2	36631218
Pubmed	Apoptotic cell-derived ICAM-3 promotes both macrophage chemoattraction to and tethering of apoptotic cells.	ICAM5 ICAM3	2.83e-06	2	59	2	22117198
Pubmed	Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease.	MSTN GDF11	2.83e-06	2	59	2	27304512
Pubmed	Reduced Circulating GDF11 Is Unlikely Responsible for Age-Dependent Changes in Mouse Heart, Muscle, and Brain.	MSTN GDF11	2.83e-06	2	59	2	26372181
Pubmed	Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation.	MSTN GDF11	2.83e-06	2	59	2	27034275
Pubmed	Supraphysiological levels of GDF11 induce striated muscle atrophy.	MSTN GDF11	2.83e-06	2	59	2	28270449
Pubmed	Essential amino acids increase microRNA-499, -208b, and -23a and downregulate myostatin and myocyte enhancer factor 2C mRNA expression in human skeletal muscle.	MSTN MEF2C	2.83e-06	2	59	2	19828686
Pubmed	Redundancy of myostatin and growth/differentiation factor 11 function.	MSTN GDF11	2.83e-06	2	59	2	19298661
Pubmed	Myostatin and the control of skeletal muscle mass.	MSTN GDF11	2.83e-06	2	59	2	10508689
Pubmed	SOCS-1 binding to tyrosine 441 of IFN-gamma receptor subunit 1 contributes to the attenuation of IFN-gamma signaling in vivo.	IFNGR1 SOCS1	8.48e-06	3	59	2	19734231
Pubmed	Crystal structure of the WFIKKN2 follistatin domain reveals insight into how it inhibits growth differentiation factor 8 (GDF8) and GDF11.	MSTN GDF11	8.48e-06	3	59	2	30814254
Pubmed	Regulation of cytokine-driven functional differentiation of CD8 T cells by suppressor of cytokine signaling 1 controls autoimmunity and preserves their proliferative capacity toward foreign antigens.	IFNGR1 SOCS1	8.48e-06	3	59	2	20519645
Pubmed	Myostatin regulates fiber-type composition of skeletal muscle by regulating MEF2 and MyoD gene expression.	MSTN MEF2C	8.48e-06	3	59	2	19129464
Pubmed	The effects of concurrent training order on body composition and serum concentrations of follistatin, myostatin and GDF11 in sarcopenic elderly men.	MSTN GDF11	8.48e-06	3	59	2	32035222
Pubmed	MACF1 links Rapsyn to microtubule- and actin-binding proteins to maintain neuromuscular synapses.	RAPSN MACF1	8.48e-06	3	59	2	30842214
Pubmed	Structural basis for potency differences between GDF8 and GDF11.	MSTN GDF11	8.48e-06	3	59	2	28257634
Pubmed	Relationship of muscle function to circulating myostatin, follistatin and GDF11 in older women and men.	MSTN GDF11	8.48e-06	3	59	2	30165829
Pubmed	Conditionals by inversion provide a universal method for the generation of conditional alleles.	SCN9A MSTN GDF11	1.32e-05	27	59	3	23918385
Pubmed	Role of tyrosine 441 of interferon-gamma receptor subunit 1 in SOCS-1-mediated attenuation of STAT1 activation.	IFNGR1 SOCS1	1.69e-05	4	59	2	15522878
Pubmed	Characterization of follistatin-related gene as a negative regulatory factor for activin family members during mouse heart development.	MSTN GDF11	1.69e-05	4	59	2	17878677
Pubmed	Both WFIKKN1 and WFIKKN2 have high affinity for growth and differentiation factors 8 and 11.	MSTN GDF11	1.69e-05	4	59	2	18596030
Pubmed	Differential antagonism of activin, myostatin and growth and differentiation factor 11 by wild-type and mutant follistatin.	MSTN GDF11	1.69e-05	4	59	2	18535106
Pubmed	The intercellular adhesion molecule (ICAM) family of proteins. New members and novel functions.	ICAM5 ICAM3	1.69e-05	4	59	2	9638475
Pubmed	A novel serine-rich motif in the intercellular adhesion molecule 3 is critical for its ezrin/radixin/moesin-directed subcellular targeting.	ICAM5 ICAM3	1.69e-05	4	59	2	11784723
Pubmed	Activated apoptotic cells induce dendritic cell maturation via engagement of Toll-like receptor 4 (TLR4), dendritic cell-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin (DC-SIGN), and β2 integrins.	ICAM5 ICAM3	2.82e-05	5	59	2	22396536
Pubmed	Overexpression of Latent TGFβ Binding Protein 4 in Muscle Ameliorates Muscular Dystrophy through Myostatin and TGFβ.	MSTN GDF11	2.82e-05	5	59	2	27148972
Pubmed	Cooperation between MEF2 and PPARgamma in human intestinal beta,beta-carotene 15,15'-monooxygenase gene expression.	MEF2C BCO1	2.82e-05	5	59	2	16504037
Pubmed	Large-scale candidate gene analysis of spontaneous clearance of hepatitis C virus.	IFNGR1 ICAM5 ICAM3 SOCS1	4.05e-05	112	59	4	20331378
Pubmed	BMP-11 and myostatin support undifferentiated growth of human embryonic stem cells in feeder-free cultures.	MSTN GDF11	4.23e-05	6	59	2	19751112
Pubmed	SOCS-1 protects against Chlamydia pneumoniae-induced lethal inflammation but hampers effective bacterial clearance.	IFNGR1 SOCS1	4.23e-05	6	59	2	18322213
Pubmed	Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy.	BRD9 BCL11A	4.23e-05	6	59	2	23644491
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	TMEM132A MACF1 HECTD1 SSPOP	7.23e-05	130	59	4	12421765
Pubmed	Autoregulation of neurogenesis by GDF11.	MSTN GDF11	7.87e-05	8	59	2	12546816
Pubmed	A counter gradient of Activin A and follistatin instructs the timing of hair cell differentiation in the murine cochlea.	MSTN GDF11	7.87e-05	8	59	2	31187730
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	ZFHX4 SUGP2 PARVA MACF1 SSB	1.18e-04	282	59	5	23667531
Pubmed	Autoantibody of NRIP, a novel AChR-interacting protein, plays a detrimental role in myasthenia gravis.	RAPSN MACF1	1.26e-04	10	59	2	33773096
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	IFNGR1 CELSR1 FBXO22 ERO1B MRC2 TMEM132A CD44 HECTD1 POFUT2	1.80e-04	1201	59	9	35696571
Pubmed	Silencing suppressor of cytokine signaling-1 (SOCS1) in macrophages improves Mycobacterium tuberculosis control in an interferon-gamma (IFN-gamma)-dependent manner.	IFNGR1 SOCS1	1.85e-04	12	59	2	21622562
Pubmed	Electronic medical records and genomics (eMERGE) network exploration in cataract: several new potential susceptibility loci.	GAN MEF2C	2.18e-04	13	59	2	25352737
Pubmed	A non-autonomous function of the core PCP protein VANGL2 directs peripheral axon turning in the developing cochlea.	CELSR1 CD44	2.54e-04	14	59	2	29784671
Pubmed	The NLRP12 inflammasome recognizes Yersinia pestis.	IFNGR1 NLRP12	2.54e-04	14	59	2	22840842
Pubmed	Lack of cadherins Celsr2 and Celsr3 impairs ependymal ciliogenesis, leading to fatal hydrocephalus.	CELSR1 SSPOP	2.93e-04	15	59	2	20473291
Pubmed	Regulation of GDF-11 and myostatin activity by GASP-1 and GASP-2.	MSTN GDF11	2.93e-04	15	59	2	24019467
Pubmed	Polymorphisms in innate immunity genes and risk of childhood leukemia.	ICAM5 ICAM3 SOCS1 MUC7	4.22e-04	206	59	4	20438785
Pubmed	Risk of meningioma and common variation in genes related to innate immunity.	ICAM5 ICAM3 SOCS1 MUC7	4.29e-04	207	59	4	20406964
Pubmed	Common variation in genes related to innate immunity and risk of adult glioma.	ICAM5 ICAM3 SOCS1 MUC7	4.37e-04	208	59	4	19423540
Pubmed	The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.	SUGP2 PARVA RBM6 HECTD1	4.70e-04	212	59	4	33853758
Pubmed	Developmental diversification of cortical inhibitory interneurons.	CELSR1 BCL11A MEF2C	5.07e-04	91	59	3	29513653
Pubmed	Deletion of Fibroblast growth factor 9 globally and in skeletal muscle results in enlarged tuberosities at sites of deltoid tendon attachments.	RAPSN MEF2C	5.27e-04	20	59	2	34091985
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	USP31 SUGP2 VPS8 MACF1 BCL11A	6.38e-04	407	59	5	12693553
Pubmed	Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	VPS8 MACF1 PCNX1	6.87e-04	101	59	3	9872452
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	USP31 MTMR14 DHX38 PCNX1 SSB	7.35e-04	420	59	5	28065597
Pubmed	Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	LRRC37A LRRC37A3 SSPOP	7.69e-04	105	59	3	9628581
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	SUGP2 DHX38 RBM6 MACF1 SSB HECTD1	8.29e-04	653	59	6	22586326
Pubmed	Construction of a human full-length cDNA bank.	CD44 SSB UQCRH	9.27e-04	112	59	3	7821789
Pubmed	Multifocal epithelial tumors and field cancerization from loss of mesenchymal CSL signaling.	CD44 MSTN GDF11	1.05e-03	117	59	3	22682244
Pubmed	BioID reveals an ATG9A interaction with ATG13-ATG101 in the degradation of p62/SQSTM1-ubiquitin clusters.	MTMR14 MRC2 INPP5B VPS8	1.41e-03	285	59	4	34369648
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DHX38 TMEM132A MACF1 ZNF407 HECTD1	1.50e-03	493	59	5	15368895
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	SUGP2 DHX38 PARVA MACF1 SSB	1.56e-03	498	59	5	36634849
Pubmed	Fine mapping and association studies of a high-density lipoprotein cholesterol linkage region on chromosome 16 in French-Canadian subjects.	GAN BCO1	1.62e-03	35	59	2	19844255
CoexpressionAtlas	B cells, B.Fo.PC, IgD+ IgM+ CD19+ CD43- CD5- CD23+, Peritoneal Cavity, avg-3	ERO1B BCL11A FCRLA MEF2C	1.42e-05	53	59	4	GSM538198_100
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)\|390C / Donor, Lineage, Cell class and subclass (all cells)	CELSR1 LRRC37A2 RBM6 ZNF407 POFUT2 ST14	2.22e-07	194	59	6	88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	CELSR1 LRRC37A2 RBM6 ZNF407 POFUT2 ST14	2.22e-07	194	59	6	a71728202493d4858342ea2756ea281cd0d99a3a
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_B-Memory_B_cells\|GI_small-bowel / Manually curated celltypes from each tissue	CELSR1 TMEM132A BCL11A FCRLA MEF2C	2.91e-06	168	59	5	8e025bb0541746e232b77ac0e31412ae71420c47
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_B\|GI_small-bowel / Manually curated celltypes from each tissue	CELSR1 TMEM132A BCL11A FCRLA MEF2C	2.91e-06	168	59	5	5535c1b8b7fde7b59a1bc0580cebdfa963aa1c39
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	CELSR1 LRRC37A2 RBM6 ZNF407 POFUT2	2.99e-06	169	59	5	665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	CELSR1 LRRC37A2 RBM6 ZNF407 POFUT2	2.99e-06	169	59	5	6614c9851537e4c21b1e45ff0cc3bad07ef9d034
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ERO1B INPP5B BCL11A FCRLA MEF2C	3.45e-06	174	59	5	59ccc5a82507463e0a316ba6286cb25ec1a4091b
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ERO1B ICAM3 DDX3Y FCRLA MEF2C	4.66e-06	185	59	5	e913c64f9b4873443d88dce270f0b7b6d1b4cbce
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERO1B MACF1 BCL11A FCRLA MEF2C	5.04e-06	188	59	5	1f07e3ab87173426fe0c429f5c084fb3425effd3
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERO1B MACF1 BCL11A FCRLA MEF2C	5.04e-06	188	59	5	85746f95319e494efdc1bbc24331698688d3a900
ToppCell	10x5'-GI_large-bowel-Lymphocytic_B-GC_B_(II)\|GI_large-bowel / Manually curated celltypes from each tissue	MTMR14 BCL11A FCRLA MEF2C ST14	5.30e-06	190	59	5	fee64bacbb330d04dc1dc63909838f2c605d9f1f
ToppCell	3'_v3-bone_marrow-Myeloid_Dendritic-pDC\|bone_marrow / Manually curated celltypes from each tissue	SCN9A BCL11A FCRLA MEF2C ST14	5.30e-06	190	59	5	dde0e34f6a06cdbbb65c86472360c09f0279a572
ToppCell	3'_v3-bone_marrow-Myeloid_Dendritic\|bone_marrow / Manually curated celltypes from each tissue	SCN9A BCL11A FCRLA MEF2C ST14	5.30e-06	190	59	5	6892c603037b61ef88d6ca01b7592dc0d347d63b
ToppCell	3'-Child04-06-SmallIntestine-Hematopoietic-B_cells-LZ_GC_cell\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MTMR14 SOCS1 BCL11A FCRLA MEF2C	6.01e-06	195	59	5	cccc9c70bb8f6df8c6ab94534c17475af1d3e224
ToppCell	severe-pDC\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SCN9A BCL11A FCRLA MEF2C ST14	6.48e-06	198	59	5	22da4a29b9ff8b94d98bc69b4632a2a58d5dd9e6
ToppCell	Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ANGPTL2 ZFHX4 MRC2 SCN9A GDF11	6.64e-06	199	59	5	a13f4b8a039304e685464cc8879659824cad5a3e
ToppCell	PND01-Immune-Immune_Lymphocytic_T/NK\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ERO1B BCL11A FCRLA MEF2C	4.45e-05	148	59	4	b78dac56b333bf901136ccafb0999f345e978f51
ToppCell	Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	ICAM5 TMEM132A GSG1L RNF39	4.68e-05	150	59	4	9d5bbdca19da60e1a2121ef64ec8e1375a5dbf6d
ToppCell	PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ERO1B BCL11A FCRLA MEF2C	4.81e-05	151	59	4	ee56b88c56c3b6a5ec9644c43cae521ea0e05920
ToppCell	PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ERO1B BCL11A FCRLA MEF2C	4.81e-05	151	59	4	2c239b09970acbaa90c5ebe1097f453c516f868e
ToppCell	PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ERO1B BCL11A FCRLA MEF2C	4.93e-05	152	59	4	b750302d442160a1007659c2386ac90282bf95d2
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-5\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CELSR1 BCL11A FCRLA MEF2C	5.19e-05	154	59	4	020697ae8463b18f9b4270c404f52ce4c0e90135
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CELSR1 BCL11A FCRLA MEF2C	5.46e-05	156	59	4	4e4b94580969a9736ca28df79715535a4bd1f9b2
ToppCell	droplet-Thymus-nan-18m-Myeloid-B_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERO1B BCL11A FCRLA MEF2C	5.59e-05	157	59	4	a9e077f686382303f0437ebfa4f11d273ba9fe40
ToppCell	3'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-CLP\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CELSR1 INPP5B ICAM3 BCL11A	5.59e-05	157	59	4	d12f343454202da86a06d0369f8ffe5662cd091b
ToppCell	3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TRIM58 BCL11A FCRLA MEF2C	6.32e-05	162	59	4	fc313fb2c55957faa8c9ca4023b3fce63527c267
ToppCell	3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TRIM58 BCL11A FCRLA MEF2C	6.32e-05	162	59	4	002fac3c5c3030950f9eb9e887d59902586d8452
ToppCell	3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TRIM58 BCL11A FCRLA MEF2C	6.32e-05	162	59	4	08b7f06580d516307516d5475a5dae0fa040f1a4
ToppCell	3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TRIM58 BCL11A FCRLA MEF2C	6.32e-05	162	59	4	1fda21a303a08aff6f97819cd8766cd18784d8bc
ToppCell	Healthy_Control-Lymphoid-Plasma\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	ZNF597 FBXO22 SCN9A MEF2C	6.47e-05	163	59	4	2913ccdd4613472cd82077d4993e1d9f8b223398
ToppCell	Healthy_Control-Lymphoid-Plasma-\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	ZNF597 FBXO22 SCN9A MEF2C	6.47e-05	163	59	4	b589ff57d58dcb215ee3b5a10d81f43e5752a196
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_naive-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	RBM6 BCL11A FCRLA MEF2C	6.78e-05	165	59	4	8003fd2aa3f5c9d0e99054af4ad2d79a4a3c4829
ToppCell	droplet-Lung-immune-endo-depleted-3m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USP31 BCL11A FCRLA MEF2C	6.78e-05	165	59	4	22293c6b55f44636440cd737efb786ff5de3373d
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-1\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CELSR1 BCL11A FCRLA MEF2C	6.78e-05	165	59	4	fead3f2032f8fa5f7f0159a4434989b3d65debbb
ToppCell	facs-Heart-RA-18m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERO1B BCL11A FCRLA ST14	6.94e-05	166	59	4	fc2cf67311c86fda75b35fcd4768b6f6f14c59d0
ToppCell	367C-Myeloid-Monocyte-CD16+_Monocyte\|367C / Donor, Lineage, Cell class and subclass (all cells)	ZNF597 LRRC37A MTMR14 ST14	6.94e-05	166	59	4	430d604f5bef9fae20dc81492e6695616f6701a3
ToppCell	facs-Heart-RA-18m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERO1B BCL11A FCRLA ST14	6.94e-05	166	59	4	33a6876d06e26176135a73a77c19e634ec53f7ce
ToppCell	facs-Lung-EPCAM-24m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERO1B BCL11A FCRLA MEF2C	7.11e-05	167	59	4	691f3589de0f8c13f9137812cfa9040c07d237b4
ToppCell	mild-Lymphocytic-B_cells_2\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	BCL11A FCRLA MEF2C BCO1	7.11e-05	167	59	4	0811f7559c2a7151693771e52e14af3978997118
ToppCell	facs-Thymus-nan-3m-Myeloid-macrophage\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BCL11A FCRLA MEF2C ST14	7.27e-05	168	59	4	d72cd8238fa793bb3e4add4c59eaaaadcea9930d
ToppCell	droplet-Thymus-nan-21m-Myeloid-nan\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BCL11A FCRLA GDF11 MEF2C	7.27e-05	168	59	4	69dd747be46e7fbcec571cddd6dee374b9c2507a
ToppCell	facs-Thymus-nan-3m-Myeloid-macrophage\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BCL11A FCRLA MEF2C ST14	7.27e-05	168	59	4	c34c52165485f612add7a3e35a175d5a6e365e7c
ToppCell	droplet-Kidney-nan-21m-Lymphocytic-plasma_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERO1B CD44 FCRLA SSPOP	7.27e-05	168	59	4	bc7d5f0e5d222922eaf1c8e8c87aab189209d6b6
ToppCell	facs-Thymus-nan-3m-Myeloid\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BCL11A FCRLA MEF2C ST14	7.27e-05	168	59	4	d2afc097ae1243574210be6a751685f949ea941a
ToppCell	B_cell\|World / lung cells shred on cell class, cell subclass, sample id	ICAM3 BCL11A FCRLA MEF2C	7.61e-05	170	59	4	cec4090ba6a9c934d5f6f9e4aa7823f3713319b7
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SCN9A BCL11A FCRLA MEF2C	7.61e-05	170	59	4	b49f7c8a27078de2137ed04f74cfee30729cfa5e
ToppCell	droplet-Fat-Gat-18m-Lymphocytic-B_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERO1B BCL11A FCRLA MEF2C	7.61e-05	170	59	4	5185187ecf26b4c9eaa0c01ad52697ab8d075cc7
ToppCell	droplet-Thymus-nan-21m-Myeloid-professional_antigen_presenting_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD44 BCL11A FCRLA MEF2C	7.61e-05	170	59	4	29deb285d5a82c0abcc108012ca42f4b4b4d9e19
ToppCell	droplet-Thymus-nan-21m-Myeloid\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD44 BCL11A FCRLA MEF2C	7.61e-05	170	59	4	dc35d66a9a9fe6cdd7f4ec0fe7efa49d02f2b5b2
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SCN9A BCL11A FCRLA MEF2C	7.61e-05	170	59	4	92e765ae0d3adb38d3b22fddb873fd5ccad3fd44
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SCN9A BCL11A FCRLA MEF2C	7.61e-05	170	59	4	9f8b215caa1afa3cd7104c06fca7cfd790640f66
ToppCell	facs-Lung-nan-3m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERO1B BCL11A FCRLA MEF2C	7.79e-05	171	59	4	a31c23406cf6d6a17358a8fb41d392a7fb0306e0
ToppCell	facs-Lung-nan-3m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERO1B BCL11A FCRLA MEF2C	7.79e-05	171	59	4	43d8fd9b9546e84a652564fe96b514b34b06262b
ToppCell	droplet-Lung-nan-3m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERO1B BCL11A FCRLA MEF2C	8.15e-05	173	59	4	886ac1b98f709ad7131df778b83712bf8ed313de
ToppCell	facs-Thymus-Thymus_Flowthrough-18m-Myeloid-macrophage\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERO1B BCL11A FCRLA MEF2C	8.33e-05	174	59	4	2f4bc0275cbcaa830d04a4c76e042456908d2277
ToppCell	ASK452-Immune-B_cell\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	LRRC37A3 INPP5B LRRC37A2 BCL11A	8.33e-05	174	59	4	69723f5666abc3af5f0431901a60246c9915ef81
ToppCell	facs-Thymus-Thymus_Flowthrough-18m-Myeloid\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERO1B BCL11A FCRLA MEF2C	8.33e-05	174	59	4	01eff218e71a04201189a0313aaf91437fffed95
ToppCell	facs-Thymus-Thymus_Flowthrough-18m-Myeloid-macrophage\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERO1B BCL11A FCRLA MEF2C	8.33e-05	174	59	4	f0f6d135e1fb4c15022be103b00d8d5456515a18
ToppCell	normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells\|normal_Lymph_Node / Location, Cell class and cell subclass	LRRC37A LRRC37A3 SCN9A BCL11A	8.52e-05	175	59	4	29fbdfe1d3bfcb063be2bced0128a33176c5b78f
ToppCell	droplet-Kidney-KIDNEY-30m-Lymphocytic-plasma_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERO1B CD44 FCRLA MEF2C	8.71e-05	176	59	4	35610e7ac9902687e222641202409bab279c3998
ToppCell	droplet-Lung-LUNG-30m-Lymphocytic-Plasma_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERO1B FCRLA MEF2C ST14	8.71e-05	176	59	4	606704098bfdf8bfef740a3544a372fae1e75969
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-B_cell-B_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ERO1B BCL11A FCRLA MEF2C	8.71e-05	176	59	4	27c132e9852717cbc345af7a1fc390e9ea589416
ToppCell	droplet-Lung-LUNG-30m-Lymphocytic-plasma_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERO1B FCRLA MEF2C ST14	8.71e-05	176	59	4	acb9e29773030f6452a069f8f7e53eab68ab7bd3
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-B_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ERO1B BCL11A FCRLA MEF2C	8.71e-05	176	59	4	259d1864fb0a6d2feddc90bc715e2bccbb373792
ToppCell	droplet-Kidney-nan-21m-Lymphocytic-CD45____plasma_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERO1B CD44 FCRLA SSPOP	8.90e-05	177	59	4	41cbb2c109eaa7be366fc0510cce64abc06837b4
ToppCell	droplet-Fat-SCAT-30m-Lymphocytic-T_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CELSR1 RAPSN IQCC RNF39	8.90e-05	177	59	4	baf78a8dad55f124f56585f88b10b58c0269680f
ToppCell	facs-Lung-ENDOMUCIN-18m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERO1B BCL11A FCRLA MEF2C	9.10e-05	178	59	4	ba5a477257877f4a15a91c1762ffcc6f2e9f7357
ToppCell	facs-Lung-ENDOMUCIN-18m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERO1B BCL11A FCRLA MEF2C	9.10e-05	178	59	4	5634c1fbc817758092af4feafff94d107412d89b
ToppCell	facs-GAT-Fat-3m-Lymphocytic-B_cell\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERO1B BCL11A FCRLA MEF2C	9.10e-05	178	59	4	5b6f7e8a930c239db1f31edfb61b2b9228d28663
ToppCell	droplet-Liver-Hepatocytes-21m-Lymphocytic\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BCL11A FCRLA GDF11 ST14	9.10e-05	178	59	4	4289e435d465b7a1490d13bf05278f4ed77d69cd
ToppCell	mild-Lymphocytic-B_cells_2\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	BCL11A FCRLA MEF2C BCO1	9.10e-05	178	59	4	c6fb21401ad802a57e4e4f5a1723c42779fdb33e
ToppCell	normal_Lung-B_lymphocytes\|normal_Lung / Location, Cell class and cell subclass	SCN9A BCL11A FCRLA MEF2C	9.29e-05	179	59	4	5b89193486100b6754c1c5eca3105ea955805eae
ToppCell	cellseq-Immune-Lymphocytic_B-Lymphocytic_B\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ICAM3 BCL11A FCRLA MEF2C	9.50e-05	180	59	4	cd04d7bf92986a5b8a0193c9b92ec47da3929bac
ToppCell	3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-FCRL4+_Memory_B\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IFNGR1 CD44 FCRLA MEF2C	9.50e-05	180	59	4	eedb6d89680f968167afb1dcd132c9de9096b50f
ToppCell	droplet-Liver-LIVER_HEP-30m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPP1R3A BRD9 MACF1 MEF2C	9.50e-05	180	59	4	dd1b10c7f5a0fbc63163844ca1882884a24a84d3
ToppCell	COVID-19-kidney-Bcells\|kidney / Disease (COVID-19 only), tissue and cell type	CD44 BCL11A FCRLA MEF2C	9.50e-05	180	59	4	5650fc7ebcdf5e0be9a217a58d36a8386d59fd1b
ToppCell	facs-MAT-Fat-24m-Lymphocytic-B_cell\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERO1B BCL11A FCRLA MEF2C	9.50e-05	180	59	4	711719219bcbafdd505790eda895e7a33f21bed2
ToppCell	cellseq-Immune-Lymphocytic_B\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ICAM3 BCL11A FCRLA MEF2C	9.50e-05	180	59	4	663a800ab70e7ab7d13183417f9c1ed36907aa5e
ToppCell	droplet-Liver-LIVER_HEP\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPP1R3A BRD9 MACF1 MEF2C	9.50e-05	180	59	4	423454e3390080ae03bb3cbb267255ebfe4df080
ToppCell	Severe-Lymphoid-pDC\|Severe / Condition, Lineage, Cell class and cell subclass	SCN9A BCL11A FCRLA MEF2C	9.70e-05	181	59	4	2caecb7c5dcdad46fd02b4ffb73cb613ce835187
ToppCell	facs-SCAT-Fat-18m-Lymphocytic-B_cell\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERO1B BCL11A FCRLA MEF2C	9.70e-05	181	59	4	3510e0ecd4f098e8553946c44c2a49587d543755
ToppCell	(1)_B_cells-(1)_B_CD27pos\|(1)_B_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	CD44 SOCS1 DDX3Y UQCRH	9.70e-05	181	59	4	d2476956ca13f9234d7e77c3ee432dd54eebeac4
ToppCell	10x5'-Liver-Lymphocytic_B-Memory_B_cells\|Liver / Manually curated celltypes from each tissue	CELSR1 BCL11A FCRLA MEF2C	9.70e-05	181	59	4	a9f4df288c34e3b2b6ed861ac6cda970c3ee08b1
ToppCell	Severe-Lymphoid-pDC-\|Severe / Condition, Lineage, Cell class and cell subclass	SCN9A BCL11A FCRLA MEF2C	9.70e-05	181	59	4	277ce4c49121da0990a5933b19d2c6af9bbe253e
ToppCell	cellseq-Immune-Lymphocytic_B-Lymphocytic_B-B\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ICAM3 BCL11A FCRLA MEF2C	9.91e-05	182	59	4	dc6b5ce410c1a7cade60ae17cbbe8548c088cba8
ToppCell	normal-na-Lymphocytic_B-B_mem-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	DDX3Y BCL11A FCRLA MEF2C	9.91e-05	182	59	4	ee36ea6cb9a5a08aeb83f2b7a249255f0b1a9870
ToppCell	droplet-Mammary_Gland-nan-21m-Lymphocytic-B_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERO1B BCL11A FCRLA MEF2C	9.91e-05	182	59	4	97f393549c7718a32af55b2377801bfebb10cc52
ToppCell	E18.5-samps-Mesenchymal-Myofibroblast\|E18.5-samps / Age Group, Lineage, Cell class and subclass	ANGPTL2 SUGP2 C11orf96 BCL11A	1.01e-04	183	59	4	de08f9ea02b7244d5a8788064631d10f06565337
ToppCell	droplet-Lung-30m-Hematologic-lymphocytic-plasma_cell-plasma_cell\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ERO1B FCRLA MEF2C ST14	1.01e-04	183	59	4	0f6799e4f058bed546fe5759502430f4a19635da
ToppCell	facs-Thymus-Flowthrough-24m-Myeloid\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERO1B BCL11A FCRLA MEF2C	1.01e-04	183	59	4	0513bb73552bfee609877d924fa97684200f595c
ToppCell	facs-Thymus-Flowthrough-24m-Myeloid-macrophage\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERO1B BCL11A FCRLA MEF2C	1.01e-04	183	59	4	6eeef55071ae25a61616df4fcfb2cea560aa7923
ToppCell	droplet-Mammary_Gland-nan-21m-Lymphocytic-B_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERO1B BCL11A FCRLA MEF2C	1.01e-04	183	59	4	e7038532a6e159bb3e383cdd9c44b3b7f21c0c01
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Lymphocytic-B_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERO1B BCL11A FCRLA MEF2C	1.01e-04	183	59	4	544939a0bfef082d361d88ef70d6f0923b8d9af9
ToppCell	droplet-Kidney-nan-24m-Lymphocytic-CD45____plasma_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERO1B CD44 FCRLA MEF2C	1.01e-04	183	59	4	edb0069c66b1465dcc0bb5881417c6b17184fd74
ToppCell	facs-Thymus-Flowthrough-24m-Myeloid-macrophage\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERO1B BCL11A FCRLA MEF2C	1.01e-04	183	59	4	85b2335fa938a94e74251bd8d99de1bd21265ac9
ToppCell	droplet-Lung-30m-Hematologic-lymphocytic-plasma_cell\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ERO1B FCRLA MEF2C ST14	1.01e-04	183	59	4	8ef5223e46f1fd81a856261248cc77e7c7e72ef6
ToppCell	3'_v3-blood-Lymphocytic_B-Memory_B_cells\|blood / Manually curated celltypes from each tissue	CELSR1 BCL11A FCRLA MEF2C	1.01e-04	183	59	4	e3a418b745d7f040adf47be9e1043b945cae47ed
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMPRSS15 ZFHX4 SCN9A SSPOP	1.03e-04	184	59	4	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	wk_20-22-Hematologic_Lymphocytic-B-CD5+_CCL22+_mature_B\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	ICAM3 CD44 BCL11A FCRLA	1.03e-04	184	59	4	5bb775253a10a14360b06a46aba46d162a9bd1f8
ToppCell	droplet-Kidney-nan-24m-Lymphocytic-plasma_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERO1B CD44 FCRLA MEF2C	1.03e-04	184	59	4	82d2daa39e3c31a74c08a5d77366740b87beb2fb
Drug	Pindolol [13523-86-9]; Up 200; 16.2uM; MCF7; HT_HG-U133A	RAPSN ERO1B MRC2 PARVA PCNX1 MEF2C	1.20e-05	197	59	6	2238_UP
Drug	(-)-MK 801 hydrogen maleate [77086-19-2]; Up 200; 11.8uM; HL60; HT_HG-U133A	ZFHX4 IQCC MRC2 CD44 POFUT2 MEF2C	1.30e-05	200	59	6	3081_UP
Drug	Propofol [2078-54-8]; Up 200; 22.4uM; MCF7; HT_HG-U133A	ANGPTL2 ERO1B MRC2 SOCS1 ZNF407	1.24e-04	187	59	5	3386_UP
Drug	3-sulfoglucuronic acid	ICAM5 CD44	1.37e-04	7	59	2	CID000130628
Drug	Mebeverine hydrochloride [2753-45-9]; Up 200; 8.6uM; PC3; HT_HG-U133A	INPP5B TMEM132A PARVA PCNX1 BCL11A	1.44e-04	193	59	5	7147_UP
Drug	Norfloxacin [70458-96-7]; Down 200; 12.6uM; MCF7; HT_HG-U133A	SUGP2 MRC2 CD44 PCNX1 XRCC2	1.44e-04	193	59	5	5985_DN
Drug	Norfloxacin [70458-96-7]; Down 200; 12.6uM; PC3; HT_HG-U133A	IFNGR1 TRIM58 CD44 PCNX1 MEF2C	1.47e-04	194	59	5	7283_DN
Drug	Clorsulon [60200-06-8]; Down 200; 10.6uM; PC3; HT_HG-U133A	DHX38 TMEM132A PCNX1 XRCC2 GDF11	1.51e-04	195	59	5	7264_DN
Drug	Methacholine chloride [62-51-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A	ANGPTL2 IQCC SOCS1 XRCC2 MEF2C	1.51e-04	195	59	5	3452_UP
Drug	Napelline [5008-52-6]; Up 200; 11.2uM; MCF7; HT_HG-U133A	ZFHX4 PARVA DDX3Y PCNX1 POFUT2	1.54e-04	196	59	5	6824_UP
Drug	Cimetidine [51481-61-9]; Down 200; 15.8uM; PC3; HT_HG-U133A	TMPRSS15 FBXO22 GAN ZNF407 MEF2C	1.54e-04	196	59	5	4063_DN
Drug	Mianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A	SUGP2 INPP5B TMEM132A ZNF407 PCNX1	1.54e-04	196	59	5	6260_UP
Drug	PNU-0251126 [267429-19-6]; Up 200; 1uM; PC3; HT_HG-U133A	TMPRSS15 MRC2 ZNF407 MUC7 MEF2C	1.54e-04	196	59	5	3692_UP
Drug	Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; HL60; HT_HG-U133A	ANGPTL2 MRC2 ICAM5 SOCS1 ZNF407	1.54e-04	196	59	5	2560_UP
Drug	Alcuronium chloride [15180-03-7]; Up 200; 5.4uM; MCF7; HT_HG-U133A	ERO1B MRC2 MYRIP BCL11A POFUT2	1.54e-04	196	59	5	4409_UP
Drug	Trimeprazine tartrate [4330-99-8]; Down 200; 5.4uM; HL60; HT_HG-U133A	ZFHX4 ICAM5 PCNX1 MEF2C ST14	1.54e-04	196	59	5	2736_DN
Drug	Eucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; HL60; HT_HG-U133A	ANGPTL2 ZFHX4 MRC2 ICAM5 ZNF407	1.58e-04	197	59	5	2556_UP
Drug	LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A	IQCC ICAM5 INPP5B CD44 PCNX1	1.62e-04	198	59	5	6976_UP
Drug	Fluorocurarine chloride [22273-09-2]; Up 200; 11.6uM; HL60; HT_HG-U133A	ANGPTL2 ICAM5 MYRIP SOCS1 ST14	1.62e-04	198	59	5	2521_UP
Drug	Diperodon hydrochloride [537-12-2]; Down 200; 9.2uM; PC3; HT_HG-U133A	ERO1B INPP5B PARVA SCN9A MEF2C	1.62e-04	198	59	5	4498_DN
Drug	Butirosin disulfate salt [51022-98-1]; Down 200; 5.4uM; MCF7; HT_HG-U133A	RAPSN IQCC INPP5B PARVA PCNX1	1.62e-04	198	59	5	6080_DN
Drug	Furaltadone hydrochloride [3759-92-0]; Up 200; 11uM; PC3; HT_HG-U133A	FBXO22 ANGPTL2 ERO1B PARVA MUC7	1.62e-04	198	59	5	3756_UP
Drug	Tetrahydroxy-1,4-quinone monohydrate [319-89-1]; Down 200; 21uM; PC3; HT_HG-U133A	TMPRSS15 CELSR1 FBXO22 ERO1B ST14	1.62e-04	198	59	5	4078_DN
Drug	PF-01378883-00 [351320-41-7]; Up 200; 10uM; PC3; HT_HG-U133A	SCN9A SOCS1 ZNF407 PCNX1 MEF2C	1.66e-04	199	59	5	6410_UP
Drug	Proguanil hydrochloride [637-32-1]; Down 200; 13.8uM; MCF7; HT_HG-U133A	FBXO22 SUGP2 MRC2 CD44 XRCC2	1.66e-04	199	59	5	5506_DN
Drug	Gly-His-Lys acetate salt; Down 200; 1uM; PC3; HT_HG-U133A	CELSR1 INPP5B TMEM132A PARVA BCL11A	1.66e-04	199	59	5	6560_DN
Drug	iloprost; Up 200; 1uM; SKMEL5; HG-U133A	SUGP2 PARVA SOCS1 BCL11A ST14	1.66e-04	199	59	5	496_UP
Drug	Albendazole [54965-21-8]; Up 200; 15uM; MCF7; HT_HG-U133A	CELSR1 INPP5B DDX3Y BCL11A MEF2C	1.66e-04	199	59	5	3164_UP
Drug	Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A	ERO1B ZFHX4 CD44 ZNF407 MEF2C	1.66e-04	199	59	5	4765_DN
Drug	Nystatine [1400-61-9]; Down 200; 4.4uM; MCF7; HT_HG-U133A	SUGP2 SOCS1 GAN PCNX1 XRCC2	1.69e-04	200	59	5	4807_DN
Drug	Spiramycin [8025-81-8]; Up 200; 4.8uM; HL60; HT_HG-U133A	FBXO22 ANGPTL2 ZFHX4 TRIM58 ST14	1.69e-04	200	59	5	2558_UP
Drug	Gabazine [105538-73-6]; Up 200; 10.8uM; MCF7; HT_HG-U133A	TMPRSS15 ANGPTL2 ERO1B MRC2 PCNX1	1.69e-04	200	59	5	4820_UP
Drug	(R)-(+)-Atenolol [56715-13-0]; Down 200; 15uM; MCF7; HT_HG-U133A	SUGP2 MTMR14 MRC2 DHX38 PCNX1	1.69e-04	200	59	5	4841_DN
Drug	Naringin hydrate [11032-30-7]; Up 200; 6.6uM; PC3; HT_HG-U133A	TMPRSS15 PARVA GAN ZNF407 PCNX1	1.69e-04	200	59	5	4605_UP
Drug	Tetrandrine [518-34-3]; Up 200; 6.4uM; HL60; HT_HG-U133A	ANGPTL2 ERO1B ZFHX4 MEF2C ST14	1.69e-04	200	59	5	2520_UP
Disease	vertebral hypersegmentation and orofacial anomalies (implicated_via_orthology)	MSTN GDF11	3.80e-06	2	58	2	DOID:0070418 (implicated_via_orthology)
Disease	arthritis	GAN BCO1	1.14e-05	3	58	2	EFO_0005856
Disease	butyrylcholinesterase measurement	NLRP12 TRIM58	5.67e-05	6	58	2	EFO_0004571
Disease	protein-tyrosine sulfotransferase 2 measurement	NLRP12 RAPSN	1.06e-04	8	58	2	EFO_0801971
Disease	intercellular adhesion molecule 5 measurement	ICAM5 ICAM3	2.92e-04	13	58	2	EFO_0008164
Disease	platelet-to-lymphocyte ratio	RAPSN TRIM58 ICAM5 ICAM3 MEF2C	7.36e-04	363	58	5	EFO_0008446
Disease	ICAM-1 measurement	ICAM5 ICAM3	1.02e-03	24	58	2	EFO_0004520
Disease	loneliness measurement	RAPSN SUDS3 MACF1	1.89e-03	124	58	3	EFO_0007865

Protein segments in the cluster

Peptide	Gene	Start	Entry
REREHCDTEGEADDF	BRD9	96	Q9H8M2
RDHFCELDDERSPAA	ERO1B	161	Q86YB8
RDGSEEDFHLDCRHE	GSG1L	281	Q6UXU4
RDCLQALEDGHDTSS	ANGPTL2	276	Q9UKU9
EDFTGEHCEVDARSG	CELSR1	1391	Q9NYQ6
CFADIHRSRGDLETA	RAPSN	251	Q13702
ELCDERVSSRSHTEE	UQCRH	51	P07919
RTTGELEQEDDSCHR	IQCC	236	Q4KMZ1
ADSETFISLEECRGH	FBXO22	106	Q8NEZ5
CHRRSLQEDEEGFSR	LRRC37A3	1606	O60309
CHRRSLQEDEEGFSR	LRRC37A2	1606	A6NM11
CHRRSLQEDEEGFSR	LRRC37A	1606	A6NMS7
FSGDLDDQTCREDLH	SSB	236	P05455
DVTEEDCALRSGDTH	MTMR14	176	Q8NCE2
LHCEDGSDEADCVRF	TMPRSS15	666	P98073
AEAEGHRDTCDEDSV	BCL11A	576	Q9H165
HRDTCDEDSVAGESD	BCL11A	581	Q9H165
FCHDEDSSDQSDLSR	PCNX1	596	Q96RV3
DDRRSFFCDATLDVD	ICAM5	376	Q9UMF0
NFDRSRHDDDDIRGC	MRC2	771	Q9UBG0
SCSSSYDGSDREDHR	MEF2C	426	Q06413
DEEDSGREIFLSCSH	MACF1	2266	Q9UPN3
RDDHGAPFSCRTELD	ICAM3	181	P32942
DLGCLRRDFHSDTSA	PPP1R3A	481	Q16821
CFSFSEGRERDHELR	MUC7	16	Q8TAX7
RGDRDLHCTESQSEA	HECTD1	2291	Q9ULT8
ENEDERDRHLSFSGS	CD44	281	P16070
CHTEDDLTDAREAGF	FCRLA	46	Q7L513
SSFREESRFCDAHLV	GAN	21	Q9H2C0
SRRNLGLDCDEHSSE	GDF11	296	O95390
LRSEFEHIRDCLDTG	INPP5B	856	P32019
DSICSRRGTSEEHEA	KATNA1	311	O75449
CTSIHGDRSQRDREE	DDX3Y	466	O15523
VTDSGRHILEDSCAE	SDE2	286	Q6IQ49
DHSRNGFDTDSSCLE	IFNGR1	406	P15260
SHADFRGRDLSDLDF	RBM6	191	P78332
CDGREDCLDGSDERH	SSPOP	2411	A2VEC9
AEASDEAERRARGCH	TMEM132A	526	Q24JP5
DEFRSRHLNSTDDAD	POFUT2	251	Q9Y2G5
RDFGLDCDEHSTESR	MSTN	266	O14793
ADDEHSIFGDNESRR	SCN9A	571	Q15858
EFLCSPDDDSRHSER	VPS8	861	Q8N3P4
LSGRHERDAFDTLFD	PARVA	241	Q9NVD7
HLDGSRESFDCLFEL	SOCS1	136	O15524
SEEQRDRASDCHGAP	BCO1	531	Q9HAY6
RAFISRDCGSDAAED	C11orf96	71	Q7Z7L8
SLGARTCDDDLTEQH	ZFHX4	1086	Q86UP3
RSFDLASCDERGSDL	ST14	261	Q9Y5Y6
ECGRDLEFSHSDSRD	SUGP2	106	Q8IX01
EDASIHRLEGTDLDC	DHX38	6	Q92620
SEEPSHASRRLCDVD	XRCC2	206	O43543
ESAQHEDGRDSEACR	ZNF213	31	O14771
KSHDEDSERCSDDGD	ZNF597	316	Q96LX8
RSFCDTDDLETVHES	USP31	376	Q70CQ4
TCDFSSMSRRDLDEH	ZNF407	561	Q9C0G0
DERSCRGRESDEDTE	SUDS3	36	Q9H7L9
CARHGEDLSRFCEED	TRIM58	96	Q8NG06
CRDSSGEDADDEESH	RNF39	296	Q9H2S5
SADGEDRARCSAGAH	NLRP12	671	P59046
TELEDAARCIHSGTD	MYRIP	716	Q8NFW9